MYC and diffuse large B-cell lymphoma: We evaluated MYC protein expression in conjunction with a variety of morphologic, immunophenotypic, genetic, and clinical parameters in a large single-center series of CNS DLBCL to determine whether MYC protein expression could serve as a prognostic or theranostic biomarker.